Rodman & Renshaw Starts Titan Pharmaceuticals (TTNP) at Market Outperform
Tweet Send to a FriendGet Alerts TTNP Hot Sheet
Price: $0.45 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 2 | New: 2
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 2 | New: 2
Trade TTNP Now!
Rodman & Renshaw initiates coverage on Titan Pharmaceuticals (OTC: TTNP) with a Market Outperform. PT $4.00.
For an analyst ratings summary and ratings history on Titan Pharmaceuticals click here. For more ratings news on Titan Pharmaceuticals click here.
Shares of Titan Pharmaceuticals closed at $0.74 yesterday, with a 52 week range of $0.63-$2.22.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Titan Pharmaceuticals click here. For more ratings news on Titan Pharmaceuticals click here.
Shares of Titan Pharmaceuticals closed at $0.74 yesterday, with a 52 week range of $0.63-$2.22.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Wells Fargo Starts StealthGas (GASS) at Outperform
- Deutsche Bank Starts Quintiles (Q) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & Renshaw
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
